Keratoconus Treatment Options From Lenses to Cross-Linking
Treatment Options for Keratoconus
Keratoconus is a progressive eye condition in which the cornea gradually thins and develops an irregular, cone-like shape, leading to distorted and blurry vision. According to a 2024 study in the American Journal of Ophthalmology using CDC data, the national prevalence of keratoconus in the U.S. was 0.04% in 2019, with an estimated 132,089 diagnosed Americans, and a cumulative economic burden of $3.8 billion. If you or a family member has been diagnosed with keratoconus, understanding the full range of treatment options can help you feel confident about the path forward. Keratoconus treatment is not one-size-fits-all. The right approach depends on the severity of corneal irregularity, how quickly the condition is progressing, and how well your current vision correction is working.
In the earliest stages, mild keratoconus may be corrected with standard eyeglasses or soft contact lenses. These work well when the cornea still has a relatively regular shape and the astigmatism is minimal. As the condition advances, however, glasses and soft lenses typically become less effective at providing sharp vision.
When glasses no longer provide adequate correction, specialty contact lens fitters often recommend rigid gas permeable (RGP) lenses, scleral lenses, or hybrid designs. These lenses vault over the irregular corneal surface and create a smooth optical interface, which can dramatically improve visual clarity.
Corneal cross-linking is the only treatment proven to slow or halt the progression of keratoconus. It uses riboflavin (vitamin B2) drops and controlled ultraviolet-A light to strengthen the collagen bonds within the cornea. Cross-linking does not reverse existing corneal changes, but it can stabilize the cornea and help preserve your current level of vision.
Surgical Treatment Options
Intacs are small, arc-shaped plastic segments surgically inserted into the middle layer of the cornea. They help flatten the cone and reduce irregular astigmatism, which can improve both uncorrected vision and contact lens tolerance. Intacs are typically considered when contact lenses alone are no longer providing satisfactory correction.
For advanced keratoconus where the cornea has become severely thinned or scarred, a corneal transplant may be necessary. Modern techniques such as deep anterior lamellar keratoplasty (DALK) replace only the front layers of the cornea while preserving the inner endothelial layer, which can reduce rejection risk and speed recovery compared to full-thickness transplants. Fortunately, early treatment with cross-linking has significantly reduced the number of patients who eventually need transplant surgery.
When to Begin Keratoconus Treatment
Timing plays a critical role in keratoconus outcomes. Starting treatment at the right stage can prevent unnecessary vision loss and reduce the likelihood of needing more invasive procedures later. Keratoconus is most commonly diagnosed during the teenage years or early twenties, when the cornea is still changing. Regular corneal topography mapping allows cornea specialists to detect subtle irregularities before they cause noticeable symptoms. Patients with a family history of keratoconus or a habit of frequent eye rubbing should be screened early and monitored closely.
Treatment beyond glasses is typically recommended when vision can no longer be corrected adequately with standard lenses, when topography shows measurable progression, or when the patient experiences frequent prescription changes. A worsening of best-corrected visual acuity or increasing corneal steepness on successive topography scans are strong indicators that intervention is needed.
In younger patients with documented progression, cornea specialists often recommend corneal cross-linking as an early step before focusing on vision correction. Stabilizing the cornea first ensures that any contact lens fitting or surgical procedure performed afterward will deliver more predictable, longer-lasting results.
How Specialty Contact Lenses Help Keratoconus
Contact lenses remain the primary method of vision correction for most keratoconus patients. Specialty contact lens fitters have extensive experience with the full range of lens designs available for irregular corneas. RGP lenses sit directly on the cornea and create a tear-filled layer between the lens and the irregular surface. This layer acts as a new refractive surface, smoothing out the optical distortion caused by the cone. While RGP lenses provide excellent visual clarity, some patients find them less comfortable than other options, particularly if the cone is steep or decentered.
Scleral lenses are larger-diameter gas permeable lenses that rest on the white part of the eye (the sclera) rather than on the cornea itself. Because they vault completely over the cornea, they are often more comfortable than traditional RGP lenses and provide outstanding vision correction even in moderate to advanced keratoconus. The fluid reservoir between the lens and cornea also helps keep the eye hydrated throughout the day.
Hybrid lenses combine a rigid gas permeable center with a soft lens skirt, offering the sharp optics of an RGP with much of the comfort of a soft lens. In a piggyback system, a soft lens is worn underneath a smaller RGP lens to cushion it against the cornea. Both approaches can be useful for patients who need the visual correction of a rigid lens but struggle with comfort.
Newer custom soft contact lenses designed specifically for keratoconus can correct mild to moderate irregular astigmatism while offering the comfort patients associate with soft lenses. These are a good option for patients in the earlier stages who are not yet ready for or tolerant of rigid designs.
Frequently Asked Questions
Intacs are typically considered when contact lenses no longer provide adequate vision or comfortable wear, but the keratoconus has not progressed to the point of requiring a corneal transplant. They can also be used to improve contact lens fitting by reducing the steepness of the cone. In some cases, Intacs are combined with corneal cross-linking to both reshape and stabilize the cornea in a single treatment plan.
Yes, but the need for transplant has decreased significantly since the introduction of corneal cross-linking. A transplant is generally reserved for patients with severe corneal scarring, extreme thinning, or those who cannot achieve functional vision with any contact lens design. Modern partial-thickness transplant techniques (DALK) offer favorable outcomes with lower rejection rates than traditional full-thickness procedures.
Clinical studies have shown that corneal cross-linking halts keratoconus progression in approximately 90 to 95 percent of treated eyes. Some patients also experience a modest flattening of the cornea and mild improvement in visual acuity after the procedure, though the primary goal is stabilization rather than vision improvement. Long-term follow-up data extending beyond 10 years continues to support the durability of cross-linking results.
Recovery varies by treatment type. Contact lens fittings require an adjustment period of one to two weeks as you adapt to a new lens design. Cross-linking recovery involves several days of discomfort followed by weeks of gradual visual improvement, with full stabilization around three to six months. Intacs insertion typically involves a shorter recovery of one to two weeks, while corneal transplant recovery can take a year or longer for vision to fully stabilize.
There is currently no cure for keratoconus, but it can be managed very effectively. Cross-linking can stop the condition from worsening, and specialty contact lenses or surgical interventions can restore functional vision for the vast majority of patients. Many people with keratoconus lead active, unrestricted lives with the right combination of treatments.
Ongoing research includes accelerated cross-linking protocols that reduce procedure time, combined approaches such as cross-linking paired with topography-guided laser treatment (sometimes called CXL Plus), and advanced scleral lens designs with improved oxygen permeability. Genetic studies are also helping identify patients at risk before clinical signs appear, which may allow even earlier intervention in the future.
What our Patients say
4.8
Reviews
(3,408)